摘要
目的探讨肺癌细胞中表皮生长因子受体(EGFR)的活化与微小RNAl45(miR-145)下调之间的关系及其分子机制。方法选择正常肺上皮细胞BEAS-2B、EGFR野生型和突变型肺癌细胞A549、H292、H1650和H1975,采用实时荧光定量PCR和Western blot法检测各细胞中miR-145的表达水平和EGFR的活化水平,并分析二者的相关性。分别以EGF、特异性EGFR酪氨酸激酶抑制剂AG1478或ERK1/2抑制剂U0126处理H1975、A549和BEAS^B细胞,观察各细胞中miR-145的表达。结果肺癌细胞中EGFR的活化与miR-145的表达呈显著负相关(r=-0.926,P=0.024);EGF可下调miR-145的表达,以BEAS-2B和A549细胞内miR-145的表达下调最为明显,分别下调53.0%(t=30.993,P=0.001)和42.6%(t=14.326,P=0.005);AG1478可恢复EGFR活化诱导miR.145的下调,经AG1478处理后,H1975细胞内miR-145的表达上调67.5%(t=8.269,P=0.014)。EGFR活化后可激活下游信号蛋白分子ERK1/2,U0126可逆转EGFR活化所诱导的miR-145的下调。结论在肺癌细胞中,EGFR通过ERK1/2信号分子下调miR-145的表达。
Objective To investigate the relationship between EGFR activation and down-regulation of miRNA-145 in lung cancer. Methods Normal human lung epithelia cell line (BEAS-2B) , human lung adenocarcinoma cell lines with wild-type EGFR (A549 and H292 ) and human lung adenocarcinoma cell lines with EGFR mutation (H1975 and H1650) were chosen in this study. The levels of miRNA-145 and p- EGFR were determined by quantitative real-time PCR (qRT-PCR) and Western blotting, respectively, and the relationship between p-EGFR and miRNA-145 levels was analyzed. The miRNA-145 levels were determined by qRT-PCR after activating EGFR with EGF or blocking EGFR signal pathway with AG1478. In addition, ERK1/2 inhibitor U0126 was used to inhibit ERKI/2 activation and then the expression of miRNA-145 was detected. Results The miRNA-145 levels were closely negatively related with p-EGFR in lung cancer cells ( r = - 0. 926, P = 0. 024). EGF down-regulated miRNA-145 expression, particularly in BEAS-2B cells (53.0% ; t = 30.993, P = 0. 001 ) and A549 cells (42.6% ; t = 14. 326, P = 0. 005 ). The miRNA-145 was up-regulated after inhibiting p-EGFR with AG1478, and significantly enhanced by 67.5% in H1975 cells when treated with AG1478 ( t = 8. 269, P = 0. 014 ). The ERK1/2 signal pathway was activated by p-EGFR. U0126 restored the miRNA-145 down-regulation induced by EGFR-aetivation in lung cancer cells. Conclusion The activation of EGFR down-regulates miRNA-145 expression through ERK1/2 in lung cancer cells.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2013年第3期187-192,共6页
Chinese Journal of Oncology
基金
上海市科学技术委员会基金(10JC1409200)
上海市宝山区科委基金(10-E-3)